/R E P E A T -- Media Advisory - Customized Cancer Treatment Determined By Your Genes/

    Report Sets the Stage for Molecular Oncology and Genetic Testing Across

    TORONTO, Jan. 23 /CNW/ - Cancer Care Ontario's (CCO) Molecular Oncology
Task Force will release its first report which describes the current state and
makes recommendations on improving access to and quality of genetic testing in
Ontario to keep pace with advancing technologies in this field.
    Speakers will discuss advances in this field, the response required by
the health care system and a cancer patient's personal experience on how
genetic testing affected their cancer journey.


    -  Dr. Mary Gospodarowicz, Regional Vice President, Toronto Central
       Regional Cancer Program, CCO and Medical Director, Cancer Program,
       Princess Margaret Hospital, University Health Network

    -  Terrence Sullivan, President and CEO, CCO

    -  Mr. Richard Field, Cancer Patient

    -  Dr. Suzanne Kamel-Reid, Chair, Molecular Oncology Task Force and Co-
       Chair, Lab Services, CCO, Head of Laboratory Genetics and Director,
       Molecular Diagnostics, University Health Network, Ontario Genetics
       Secretariat Executive

    -  Dr. Tom Hudson, President and Scientific Director, Ontario Institute
       of Cancer Research

    When:   Monday, January 26th, 2009 at 10:00 a.m.

    Where:  Princess Margaret Hospital
            610 University Avenue
            7th Floor Atrium

For further information:

For further information: Media Contact: Lenore Bromley, Sr. Public
Affairs Advisor, Cancer Care Ontario, (416) 971-9800 ext. 3383,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890